← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2021Last known activity
May 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 11 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (24)
- NCT07089329Lead sponsorPhase 3May 20, 2025
- NCT07089329Sponsor investigatorPhase 3May 20, 2025
- NCT07071220Lead sponsorN/ASep 1, 2024
- NCT07083622Sponsor investigatorN/ASep 1, 2024
- NCT07071233Lead sponsorN/ASep 1, 2024
- NCT07071233Sponsor investigatorN/ASep 1, 2024
- NCT07083622Lead sponsorN/ASep 1, 2024
- NCT07071220Sponsor investigatorN/ASep 1, 2024
- NCT07139964Lead sponsorN/AJul 1, 2024
- NCT06912035Sponsor investigatorPhase 2/Phase 3Jun 21, 2024
- NCT06912035Lead sponsorPhase 2/Phase 3Jun 21, 2024
- NCT06659068Sponsor investigatorN/AMay 16, 2024
- NCT06659068Lead sponsorN/AMay 16, 2024
- NCT05869383Lead sponsorPhase 2/Phase 3May 1, 2023
- NCT05869383Overall official - principal investigatorPhase 2/Phase 3May 1, 2023
Details
- Last known activity
- May 20, 2025